SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-15-000080
Filing Date
2015-11-04
Accepted
2015-11-04 16:04:53
Documents
15
Period of Report
2015-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-20151104x8xkdoc.htm 8-K 33043
2 PRESS RELEASE pdli-20151104x8xkex991.htm EX-99.1 151390
3 PRESENTATION pdli-20151104x8xkex992.htm EX-99.2 4654
4 INFORMATION SHEET pdli-20151104x8xkex993.htm EX-99.3 543184
5 LOGO pdllogo75a01a02a01a02.jpg GRAPHIC 5218
6 slide1a12.jpg GRAPHIC 129726
7 slide2a12.jpg GRAPHIC 221518
8 slide3a12.jpg GRAPHIC 159792
9 slide4a12.jpg GRAPHIC 119171
10 slide5a12.jpg GRAPHIC 85145
11 slide6a12.jpg GRAPHIC 135834
12 slide7a12.jpg GRAPHIC 86354
13 slide8a12.jpg GRAPHIC 165964
14 slide9a09.jpg GRAPHIC 137406
15 slide12.jpg GRAPHIC 116087
  Complete submission text file 0000882104-15-000080.txt   2610743
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 151196897
SIC: 2836 Biological Products, (No Diagnostic Substances)